CN103768341A - Traditional Chinese medicine effective part composition for treating primary glaucoma - Google Patents
Traditional Chinese medicine effective part composition for treating primary glaucoma Download PDFInfo
- Publication number
- CN103768341A CN103768341A CN201310568798.5A CN201310568798A CN103768341A CN 103768341 A CN103768341 A CN 103768341A CN 201310568798 A CN201310568798 A CN 201310568798A CN 103768341 A CN103768341 A CN 103768341A
- Authority
- CN
- China
- Prior art keywords
- part composition
- primary glaucoma
- chinese medicine
- traditional chinese
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine effective part composition for treating primary glaucoma. The traditional Chinese medicine composition is prepared from the following raw materials in certain parts by weight: Chinese ash, typha orientalis, bee honey, ramie root, radix liriopes and fleshfingered citron flower. The traditional Chinese medicine effective part composition provided by the invention has the effects of dispelling wind and clearing heat, inducing dieresis and resolving phlegm, calming the adverse-rising energy and regulating vital energy, nourishing yin and suppressing yang, tonifying the liver and kidney, tonifying qi and activating blood, dispersing blood stasis and dredging collaterals, and warming liver and dispelling cold, has an obvious curative effect in treating primary glaucoma, has no side effects, and is high in safety.
Description
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to a kind of Chinese medicinal effective-part composition that is used for the treatment of primary glaucoma.
Background technology
Glaucoma, is a kind of because intraocular pressure rising causes optic papilla sunken, and defect of visual field, finally can cause blind serious oculopathy.Be divided into clinically constitutional, Secondary cases and congenital three classes.Common with constitutional.According to statistics, China's sickness rate is 0.89 ~ 2.6%, and blind rate reaches 19.62%.The morbidity of primary glaucoma, anatomical factors is fundamental cause, but emotional lability, overwork, is risk factor with transition between at the moment etc.Doctor trained in Western medicine adopts operation and myosis Drug therapy more, but can not make up to now recovered once again by the optic nerve of organic lesion and visual function.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal effective-part composition for the preparation for the treatment of primary glaucoma, this active component composition can be treated primary glaucoma, and is difficult for recurrence.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
The cause of disease of primary glaucoma is many brings out because of feelings will internal injuries such as the strongly fragrant rages of compassion, and overstrain, special overworked eyes is also one of major reason, in addition, also relevant with the heresy of affection of exogenous wind-cold, its pathogenesis is that wind-heat troubling, liver pathogen are contrary, the hepatic and renal YIN deficiency, blood stasis due to qi deficiency, liver heresy is insufficiency of the spleen.
Treat a Chinese medicinal effective-part composition for primary glaucoma, by making according to the raw material of mass fraction meter as follows: Chinese ash 25, typha orientalis 24, Mel 12, Radix Boehmeriae 18, Radix Liriopes 15 and Flos Citri Sarcodactylis 6.
The preparation method of Chinese medicinal effective-part composition of the present invention be by above-mentioned raw materials compositions according to proportioning combination drying, add 15 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, the Chinese medicinal effective-part composition of making according to proportioning of the present invention have search that wind heat clearing away, dampness removing are reduced phlegm, dispersing the stagnated live-QI to relieve the stagnation of QI, sending down the abnormal ascending QI are regulated the flow of vital energy, nourishing YIN for suppressing the hyperactive YANG, liver and kidney tonifying, inrigorating qi and promoting blood circulation, blood stasis dispelling are sensible, the effect of warming liver to dispel cold, can be used for the treatment of primary glaucoma, after curing, be difficult for recurrence.
The specific embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Chinese ash 25g, typha orientalis 24g, Mel 12g, Radix Boehmeriae 18g, Radix Liriopes 15g and Flos Citri Sarcodactylis 6g, add 15 times of water gagings after being dried, and after boiling, then uses slow fire decocting 180min with intense fire, and gained decoction is for subsequent use.
embodiment 2
500 of clinical observation Endothelium in Patients with Primary Glaucomas.Patient is all diagnosed as primary glaucoma through clinical diagnosis.Take embodiment 1 gained decoction to patient, 2 times on the 1st, sooner or later bfore meals, continuous 25 days.
Take patient's statistical result of embodiment 1 gained decoction in table 1.Wherein effectively comprise recovery from illness and effectively, recovery from illness refer to vision reach 1.0 or improve 5 row more than, intraocular pressure is normal, other transference cures; More than effectively referring to that vision improves 3 row, intraocular pressure decline 10mm mercury column or more than, other symptoms are obviously improved.Invalidly refer to that, through treatment, vision, intraocular pressure are showed no significant change or change not obviously, symptom also has no improvement.
Table 1
| Number of cases | Effective | Invalid | Obvious effective rate (%) |
| 500 | 459 | 41 | 91.8 |
Known by above-mentioned data, Chinese medicine of the present invention is made after decoction, can be in 25 days the treatment primary glaucoma of highly significant.
embodiment 3
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 60d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 400ml/d, observes none example and be poisoned to death after 60 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.
Claims (4)
1. treat a Chinese medicinal effective-part composition for primary glaucoma, it is characterized in that by making according to the raw material of mass fraction meter as follows: Chinese ash 25, typha orientalis 24, Mel 12, Radix Boehmeriae 18, Radix Liriopes 15 and Flos Citri Sarcodactylis 6.
2. the Chinese medicinal effective-part composition for the treatment of primary glaucoma according to claim 1, is characterized in that described Chinese medicinal effective-part composition makes decoction.
3. described in claim 1 or 2, treat the preparation method of the Chinese medicinal effective-part composition of primary glaucoma, it is characterized in that each crude drug, according to proportioning combination drying, adding 15 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
4. the application of Chinese medicinal effective-part composition described in claim 1 or 2, is characterized in that the medicine of described Chinese medicinal effective-part composition for the preparation for the treatment of primary glaucoma.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310568798.5A CN103768341A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating primary glaucoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310568798.5A CN103768341A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating primary glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103768341A true CN103768341A (en) | 2014-05-07 |
Family
ID=50561401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310568798.5A Pending CN103768341A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating primary glaucoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103768341A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177567A (en) * | 2016-08-25 | 2016-12-07 | 吴斌 | A kind of medicine for treating glaucoma |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152452A (en) * | 2007-09-18 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating advanced glaucoma |
| CN101703687A (en) * | 2009-11-16 | 2010-05-12 | 王芬 | Chinese medicinal decoction for treating glaucoma |
-
2013
- 2013-11-15 CN CN201310568798.5A patent/CN103768341A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152452A (en) * | 2007-09-18 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating advanced glaucoma |
| CN101703687A (en) * | 2009-11-16 | 2010-05-12 | 王芬 | Chinese medicinal decoction for treating glaucoma |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177567A (en) * | 2016-08-25 | 2016-12-07 | 吴斌 | A kind of medicine for treating glaucoma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861046A (en) | Traditional Chinese medicine for treating prosopalgia | |
| CN103550435A (en) | Traditional Chinese medicine for treating tristimania | |
| CN103223124B (en) | Traditional Chinese medicine composition used for treating lobar pneumonia | |
| CN104288255A (en) | Traditional Chinese medicine preparation for treating severe acute pancreatitis | |
| CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104784482A (en) | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis | |
| CN104815092A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN103768150A (en) | Traditional Chinese medicine effective part composition for treating cataract | |
| CN103768312A (en) | Traditional Chinese medicine effective part composition for treating Meniere's disease | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN101983719A (en) | Novel medicament for treating lung cancer | |
| CN103768194A (en) | Traditional Chinese medicine effective part composition for treating rheumatic heart disease | |
| CN103432397B (en) | Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans | |
| CN104398596A (en) | Traditional Chinese medicinal formula for treating oral ulcer | |
| CN103550294B (en) | Traditional Chinese medicine effective part composition for treating urticaria | |
| CN103550592A (en) | Traditional Chinese medicinal effective part composition for treating priapism | |
| CN103585534A (en) | Traditional Chinese medicine effective part composition for treating erythema multiforme | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN104547359A (en) | Traditional Chinese medicine composition for treating spleen deficiency and dampness stagnation type eczema | |
| CN103356957B (en) | Medicine for treating stomach cancer and preparation method thereof | |
| CN103432301B (en) | Traditional Chinese medicine effective part composition for treating primary adrenocortical insufficiency | |
| CN102078387A (en) | Traditional Chinese medicine for treating fibroid and ovarian cyst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |